Drug intelligence / Profile preview

Iscador U

Development stage
Unknown
Lead developer
Iscador
Administration
Subcutaneous
01

Overview

Iscador U is a fermented, aqueous extract of European mistletoe (*Viscum album L.*) harvested from elm trees (Ulmus). [3, 5, 8] It is developed and manufactured by Iscador AG and used in anthroposophic medicine as a complementary or integrative treatment for cancer. [1, 3, 16] The product is sold as "Iscador U c. Hg", indicating it is prepared with a homeopathically diluted amount of mercury sulphate. [2, 3] Administered via subcutaneous injection, Iscador U is an approved medicinal product in several European countries, including Germany and Switzerland, for indications such as malignant and benign tumors, precancerous conditions, and prevention of tumor recurrence. [1, 4] The therapeutic action is attributed to its complex mixture of active components, primarily mistletoe lectins and viscotoxins, which are understood to exert immunomodulatory and direct cytotoxic effects, including the induction of apoptosis in cancer cells and stimulation of the patient's immune system. [7, 12, 14]

Brand names
Iscador UIscador U c. HgIscador
Other names
Mistletoe extract (elm)Viscum album (Ulmus) extract
02

Targets

28S rRNA (28S ribosomal RNA)

Beyond the preview

Go deeper on Iscador U.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iscador U.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call